8th May 2015 10:07
8 May 2015
Circassia Pharmaceuticals plc
Director Dealing
Circassia Pharmaceuticals plc ("Circassia" or "the Company") hereby provides notification that it was informed on 7 May 2015 that earlier that day Charles Swingland, 62, a Non-Executive Director of the Company transferred 265,450 ordinary shares in the Company to his Self-Invested Pension Plan ("SIPP"). The ordinary shares were sold by Mr Swingland at a price of 301.375p each to his SIPP trustees Tower Pension Trustees Limited.
Following these transactions Mr Swingland's beneficial interest remains unchanged at 5,186,302 ordinary shares representing 2.77% of the issued share capital and Total Voting Rights of the Company.
-Ends-
For further information, please contact: | |
Circassia Pharmaceuticals plc Julien Cotta, Company Secretary |
+44 (0) 1865 405560 |
Related Shares:
CIR.L